Search Result "Losar-tan Intervention For Endpoint"
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 594-605
Author(s): Femke Waanders, Laura V. de Vries, Harry van Goor, Jan-Luuk Hillebrands, Gozewijn D. Laverman, Stephan J. L. Bakker, Gerjan Navis
EarlyVascularAgeing and Hypertension -A New Model for Understanding Cardiovascular Risk
Journal: Current Hypertension Reviews
Volume: 3 Issue: 2 Year: 2007 Page: 133-136
Author(s): Peter M. Nilsson
Current Place of Beta-Blockers in the Treatment of Hypertension
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 6 Year: 2010 Page: 733-741
Author(s): Agata Bielecka-Dabrowa, Wilbert S. Aronow, Jacek Rysz, Maciej Banach
Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Journal: Current Vascular Pharmacology
Volume: 4 Issue: 3 Year: 2006 Page: 253-268
Author(s): Eva Lonn, Jasmine Grewal
Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Journal: Current Diabetes Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 63-78
Author(s): G. Neil Thomas, Brian Tomlinson
Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 23 Year: 2017 Page: 3391-3404
Author(s): Mirjam Schuchardt,Jaqueline Herrmann,Markus Tolle,Markus van der Giet
Is there any Additional Prognostic Value of Central Blood Pressure Wave Forms Beyond Peripheral Blood Pressure?
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 254-266
Author(s): Miso Sabovic, Michel E. Safar, Jacques Blacher
Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 229-239
Author(s): Asterios Karagiannis, Dimitri P. Mikhailidis, Anna I. Kakafika, Konstantinos Tziomalos, Vasilios G. Athyros
Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3002-3008
Author(s): Satoshi Imaizumi, Shin-ichiro Miura, Eiji Yahiro, Yoshinari Uehara, Issei Komuro, Keijiro Saku
Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 6 Year: 2011 Page: 715-722
Author(s): Ioanna Eleftheriadou, Costas Tsioufis, Dimitrios Tsiachris, Nicholas Tentolouris, Christodoulos Stefanadis